Immunohistochemical analysis showed that the tumor was negative for the estrogen receptor (ER), progesterone receptor (PgR), and HER2, confirming the diagnosis of triple‐negative breast cancer (TNBC). This evidence concerns the gene ESR1 and neoplasm.